Skip to content
October 4, 2026
  • IHH Healthcare Reiterates Regulatory Approvals for 2018 Fortis Investment
  • Robotics May Reshape Healthcare Beyond Surgery, Says Jitendra Singh
  • New Studies Report Findings on Appendicitis, GLP-1 Drugs and CAR-T Therapy
  • Two Lethal Doses, Seven Needles, Still Alive: Woman’s Execution Fails as US Sees First Female Death Sentence in 200 Years
tishha_logo

Tishha News

  • Home
  • News
  • Economics
  • Technology Innovations
  • Global Healthcare
  • Expert Talks
  • Web Stories
  • Home
  • Intas Pharmaceuticals

Intas Pharmaceuticals

image 52
  • News

Intas Pharmaceuticals, IntegriMedical to Introduce India’s First Needle-Free Injection System for IVF

tishha_newsDecember 30, 2025December 30, 202504 mins

Intas Pharmaceuticals has entered into an exclusive partnership with IntegriMedical to bring India’s first Needle-Free Injection System (N-FIS) to IVF…

Read More

Most Viewed

News
IHH Healthcare Reiterates Regulatory Approvals for 2018 Fortis Investment
IHH Healthcare Bhd has reiterated that its 2018 investment in…
News
Robotics May Reshape Healthcare Beyond Surgery, Says Jitendra Singh
Robotics could soon play a wider role in healthcare, extending…

Random

1

IHH Healthcare Reiterates Regulatory Approvals for 2018 Fortis Investment

  • News
2

Robotics May Reshape Healthcare Beyond Surgery, Says Jitendra Singh

  • News
3

New Studies Report Findings on Appendicitis, GLP-1 Drugs and CAR-T Therapy

  • News
4

Two Lethal Doses, Seven Needles, Still Alive: Woman’s Execution Fails as US Sees First Female Death Sentence in 200 Years

  • Global Healthcare
5

Kerala Moves Towards Regulation of Private Hospital Treatment Charges

  • News
6

Blood Donors and Blood Donation Camp Organisers Honoured at IMA Bareilly

  • News
7

Rajasthan Mandates 8-hourly ICU Patient Photos for MAA Scheme Claims

  • News
8

Stabbed in Cockpit, How Indian Pilot’s Quick Action and a Passenger Doctor Helped Save Lives

  • News
tishha_logo
TISHHA News Developed By BlazeThemes.